IL164158A0 - Method of administering an injectable antibiotic to an animal - Google Patents

Method of administering an injectable antibiotic to an animal

Info

Publication number
IL164158A0
IL164158A0 IL16415803A IL16415803A IL164158A0 IL 164158 A0 IL164158 A0 IL 164158A0 IL 16415803 A IL16415803 A IL 16415803A IL 16415803 A IL16415803 A IL 16415803A IL 164158 A0 IL164158 A0 IL 164158A0
Authority
IL
Israel
Prior art keywords
animal
administering
antibiotic
injectable antibiotic
injectable
Prior art date
Application number
IL16415803A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28454766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL164158(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of IL164158A0 publication Critical patent/IL164158A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16415803A 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to an animal IL164158A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36621202P 2002-03-21 2002-03-21
PCT/US2003/008571 WO2003079923A1 (en) 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to the ear of an animal

Publications (1)

Publication Number Publication Date
IL164158A0 true IL164158A0 (en) 2005-12-18

Family

ID=28454766

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16415803A IL164158A0 (en) 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to an animal

Country Status (15)

Country Link
US (3) US20030181398A1 (ja)
EP (1) EP1485040B2 (ja)
JP (1) JP4365222B2 (ja)
KR (1) KR20040097187A (ja)
CN (1) CN1635856A (ja)
AT (1) ATE343980T1 (ja)
AU (1) AU2003230697B2 (ja)
BR (1) BR0308523A (ja)
CA (1) CA2476327A1 (ja)
DE (1) DE60309447T3 (ja)
ES (1) ES2275092T5 (ja)
IL (1) IL164158A0 (ja)
MX (1) MXPA04009177A (ja)
WO (1) WO2003079923A1 (ja)
ZA (1) ZA200406501B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107982214B (zh) * 2016-10-26 2021-02-05 华中农业大学 兽用恩诺沙星固体脂质纳米混悬液及其制备方法
US11406617B2 (en) 2016-12-23 2022-08-09 Intervet Inc. Compounds for the treatment of bovine or swine respiratory disease
CN110072844B (zh) 2016-12-23 2023-06-02 英特维特国际股份有限公司 用于治疗溶血曼海姆菌或睡眠嗜组织菌感染的化合物
CN107802613B (zh) * 2017-11-13 2020-01-31 郑州大学 一种掩味肠道速释型替米考星微纳米干混悬剂及其制备方法
WO2020002234A1 (en) 2018-06-25 2020-01-02 Intervet International B.V. Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni
BR112020026705A2 (pt) 2018-06-25 2021-03-23 Intervet International B.V. Compostos para o tratamento de doença respiratória bovina ou suína
CN109077999A (zh) * 2018-08-31 2018-12-25 田红卫 一种长效缓释替米考星注射液及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883984A (en) * 1957-09-09 1959-04-28 Pfizer & Co C Pellet implanter
US2999020A (en) * 1959-06-09 1961-09-05 Hodges Res & Dev Co Processes for the tendering of meat
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
US5079007A (en) * 1987-07-29 1992-01-07 The Upjohn Company Controlled release of antibiotic salts from an implant
ZA889601B (en) * 1987-09-23 1989-10-25 Petrus Burger Andries A composition for use in treating animals
US5258528A (en) * 1990-11-30 1993-11-02 Warner-Lambert Company Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group
KR100296810B1 (ko) † 1993-03-12 2001-10-24 로렌스 티. 마이젠헬더 결정성세프티오퍼유리산
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Also Published As

Publication number Publication date
ES2275092T3 (es) 2007-06-01
AU2003230697A1 (en) 2003-10-08
KR20040097187A (ko) 2004-11-17
AU2003230697B2 (en) 2008-07-17
JP4365222B2 (ja) 2009-11-18
DE60309447T3 (de) 2020-04-23
MXPA04009177A (es) 2004-12-07
WO2003079923A1 (en) 2003-10-02
EP1485040B1 (en) 2006-11-02
US20030181398A1 (en) 2003-09-25
EP1485040A1 (en) 2004-12-15
CA2476327A1 (en) 2003-10-02
JP2005520624A (ja) 2005-07-14
ZA200406501B (en) 2005-06-21
EP1485040B2 (en) 2019-12-11
US20110098266A1 (en) 2011-04-28
BR0308523A (pt) 2005-02-01
US20150182454A1 (en) 2015-07-02
DE60309447T2 (de) 2007-03-29
ATE343980T1 (de) 2006-11-15
US8968759B2 (en) 2015-03-03
ES2275092T5 (es) 2020-06-17
CN1635856A (zh) 2005-07-06
DE60309447D1 (de) 2006-12-14

Similar Documents

Publication Publication Date Title
AU2014235466A8 (en) Dental devices and systems and methods for making the same
SI1758629T1 (sl) Sestav igle in nastavka za avtomatski injektor
SE0300924D0 (sv) A method to provide a triple well in an epitaxially based CMOS or BiCMOS process
EP1522719A4 (en) FUEL INJECTION METHOD IN FUEL INJECTION DEVICE
WO2006050279A3 (en) System and method to reduce discomfort using nerve stimulation
ATE299725T1 (de) Nadelloses subkutaninjektionssystem
ATE442862T2 (de) Niederviskose konzentrierte proteinformulierungen
AU2003294869A1 (en) Bipolar transistor with an improved base emitter junction and method for the production thereof
EG25822A (en) Quinolinyl-pyrrolopyrazoles
EP1398566A3 (en) Fluid injector and injection method
IL164158A0 (en) Method of administering an injectable antibiotic to an animal
AU4481599A (en) Enema syringe, enema syringe auxiliary and injector and enema method using them
GB2385377B (en) Low pressure direct injection engine system
GB0215488D0 (en) Fuel injection system
CN201520589U (zh) 一种围裙板防夹装置
WO2004008286A3 (en) Arrangements and methods for treating a subject
DE60331141D1 (de) Spritzgiessverfahren und -vorrichtung mit basismontierter zuführvorrichtung
UA84155C2 (ru) Галеновая форма флупиртина для инъекций
TR200103841T2 (tr) Tümör büyümesini önlemek için yöntem.
GB0504347D0 (en) System and method for well workover with horizontal tree
PL371655A1 (en) Fuel injection system
PL1670681T3 (pl) Żagiel ze szwami wzmacniającymi i sposób jego wytwarzania
AU2003247367A1 (en) Stimulation and injection system
AU2003281247A1 (en) Injector with self-destruction structure
AU6556700A (en) Method for producing complete units using internal pressure systems based on injection moulding with several components, and assemblies of said units